GlaxoSmithKline to slash 6,000 jobs. Competition from generic manufacturers and doubts about company pipelines are posing a serious threat to the sector and ING analysts warned of an "intellectual property meltdown" as top-selling products come off patent and sales slow dramatically.
I wasn't so sure about this in my book review of Marcia Angell's The truth about drug companies: How they deceive us and what to do about it but maybe she was right.
2 comments:
This is absolutely correct. For more information about the truth behind the drug companies and their ties to psychiatry, all of the information is at cchr.org.
Maybe not all the information you require will be on the cchr.org. As Julie says in her blogger profile "If you have any questions about Scientology, feel free to post a comment or question ... and I'll get back to you as soon as I can."
Post a Comment